Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maintenance Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02564380
What this trial is testing

Study of Pembrolizumab Maintenance Following First-Line Platinum Based Chemotherapy in Patients With Metastatic Squamous - Non-Small Cell Lung Cancer (sNSCLC)

Who this might be right for
Metastatic Squamous Non-small Cell Lung Cancer
AIO-Studien-gGmbH 41
Large-scale testing (Phase 3)Ended earlyNCT00672724
What this trial is testing

Efficacy of Ramelteon in Adults With Chronic Insomnia

Who this might be right for
Chronic Insomnia
Takeda 1,081
Not applicableStudy completedNCT06776276
What this trial is testing

A Prospective Study: Tai-chi and Post-COVID Insomnia

Who this might be right for
InsomniaCOVID - 19
Alexandria University 337
Post-approval studies (Phase 4)Study completedNCT00227968
What this trial is testing

Psychosocial Therapy Plus Maintenance Pharmacotherapy for Treating Bipolar Disorder

Who this might be right for
Bipolar Disorder
University of Pittsburgh 181
Large-scale testing (Phase 3)Study completedNCT00247390
What this trial is testing

Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.

Who this might be right for
Chronic Insomnia
Takeda 451
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07370818
What this trial is testing

To Evaluate the Efficacy and Safety of JPI-547 in Combination With Bevacizumab as Maintenance Therapy in Relapsed Ovarian Cancer

Who this might be right for
Ovarian Cancer
Onconic Therapeutics Inc. 81
Early research (Phase 1)Ended earlyNCT01915524
What this trial is testing

Trial of RNActive®-Derived Cancer Vaccine and Local Radiation in in Stage IV Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Carcinoma
CureVac 26
Testing effectiveness (Phase 2)UnknownNCT05585281
What this trial is testing

Fluzoparib Combined With QL1101 Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Who this might be right for
Ovarian Cancer
Yongpeng Wang 25
Not applicableLooking for participantsNCT06140875
What this trial is testing

Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF)

Who this might be right for
Glioblastoma
Charite University, Berlin, Germany 26
Testing effectiveness (Phase 2)Study completedNCT00325728
What this trial is testing

Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Chronic Insomnia
Takeda 74
Testing effectiveness (Phase 2)Looking for participantsNCT06463665
What this trial is testing

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

Who this might be right for
Advanced Non-squamous Non-small-cell Lung CancerAdvanced Squamous Non-Small Cell Lung CarcinomaMetastatic Non-squamous Non Small Cell Lung Cancer+5 more
Genelux Corporation 142
Large-scale testing (Phase 3)Study completedNCT00005589
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
EBMT Solid Tumors Working Party 460
Large-scale testing (Phase 3)Active Not RecruitingNCT03737643
What this trial is testing

Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients

Who this might be right for
Advanced Ovarian Cancer
AstraZeneca 1,407
Testing effectiveness (Phase 2)Looking for participantsNCT03983226
What this trial is testing

Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)

Who this might be right for
Ovarian Cancer RecurrentFallopian Tube CancerPrimary Peritoneal Carcinoma
Shanghai Gynecologic Oncology Group 167
Testing effectiveness (Phase 2)UnknownNCT05629429
What this trial is testing

Olaparib Maintenance Therapy in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
National Taiwan University Hospital 300
Testing effectiveness (Phase 2)UnknownNCT05448885
What this trial is testing

Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50
Large-scale testing (Phase 3)WithdrawnNCT01067274
What this trial is testing

ALFA-0703 Study in Older Patients With Acute Myeloblastic Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Acute Leukemia French Association
Not applicableStudy completedNCT07192770
What this trial is testing

G-CSF-Induced Bone Pain and Supportive Care Approaches

Who this might be right for
Solid TumorsChemotherapy-induced Neutropenia
Ankara Etlik City Hospital 225
Testing effectiveness (Phase 2)Study completedNCT02045446
What this trial is testing

Maintenance Chemotherapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Chemotherapy for Stage IV Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II Trial

Who this might be right for
Stage IV Non-Small Cell Lung Cancer
University of Texas Southwestern Medical Center 29
Large-scale testing (Phase 3)Looking for participantsNCT06918002
What this trial is testing

Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients

Who this might be right for
Multiple Myeloma, Newly Diagnosed
Intergroupe Francophone du Myelome 824
Next Page